Abbott Laboratories (ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	182,902	217,579	195,872	190,870	190,793	248,277
Market Cap Growth	-17.83%	11.08%	2.62%	0.04%	-23.15%	28.02%
Enterprise Value	210,019	222,210	202,267	198,494	197,615	256,300
Last Close Price	105.70	125.29	113.11	110.07	109.79	140.74

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	34.20	33.68	14.81	33.76	28.08	35.72
Forward PE	18.23	22.63	22.39	24.22	26.64	30.05
PEG Ratio	2.12	2.35	2.61	2.85	5.16	2.38
PS Ratio	3.93	4.91	4.67	4.76	4.37	5.76
PB Ratio	3.58	4.17	4.11	4.94	5.20	6.93
P/TBV Ratio	3.66	9.70	11.04	31.51	56.41	-
P/FCF Ratio	24.79	29.42	30.84	37.73	24.45	28.71
P/OCF Ratio	19.33	22.75	22.89	26.29	19.91	23.57

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	4.51	5.01	4.82	4.95	4.53	5.95
EV/EBITDA Ratio	19.46	19.90	20.14	20.42	16.99	21.42
EV/EBIT Ratio	28.59	27.59	29.64	30.64	23.63	30.42
EV/FCF Ratio	28.47	30.05	31.85	39.24	25.32	29.64

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.29	0.19	0.26	0.35	0.39	0.48
Debt / EBITDA Ratio	3.02	1.16	1.41	1.51	1.44	1.51
Debt / FCF Ratio	4.17	1.75	2.22	2.90	2.15	2.09
Net Debt / Equity Ratio	0.26	0.08	0.13	0.19	0.18	0.22
Net Debt / EBITDA Ratio	2.50	0.36	0.61	0.76	0.57	0.65
Net Debt / FCF Ratio	3.45	0.54	0.97	1.46	0.85	0.90
Asset Turnover	0.48	0.53	0.54	0.54	0.58	0.58
Inventory Turnover	2.93	3.05	2.93	2.82	3.38	3.65
Quick Ratio	0.80	1.02	1.05	1.00	1.06	1.28
Current Ratio	1.38	1.58	1.67	1.64	1.63	1.85
Return on Equity (ROE)	6.94%	12.96%	30.91%	15.11%	19.01%	20.49%
Return on Assets (ROA)	5.42%	7.38%	16.87%	7.54%	9.33%	9.82%
Return on Invested Capital (ROIC)	5.05%	11.20%	26.01%	12.40%	15.98%	16.41%
Return on Capital Employed (ROCE)	9.09%	11.72%	10.78%	10.95%	13.82%	13.73%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.95%	2.97%	6.75%	2.96%	3.56%	2.80%
FCF Yield	4.03%	3.40%	3.24%	2.65%	4.09%	3.48%
Dividend Yield	2.38%	1.89%	1.95%	1.86%	1.72%	1.28%
Payout Ratio	81.54%	63.09%	28.62%	62.14%	47.73%	45.28%
Buyback Yield / Dilution	0.08%	0.00%	0.06%	0.85%	1.40%	-0.17%
Total Shareholder Return	2.46%	1.89%	2.01%	2.71%	3.12%	1.11%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jul 28, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error